Compounds > delprostenate
Page last updated: 2024-11-12

delprostenate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

delprostenate: RN given refers to (1R-(1-alpha(2E,5Z),2beta(1E,3R*),3alpha,5alpha))-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10455722
CHEMBL ID3989453
SCHEMBL ID571387
MeSH IDM0144978

Synonyms (23)

Synonym
delprostenate
ono-1052
2,5-heptadienoic acid, 7-(2-(4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5- dihydroxycyclopentyl)-, methyl ester, (1r-(1-alpha(2e,5z),2-beta(1e,3r*),3-alpha,5-alpha))-
ono 1052
16-(3-chlorophenoxy)-17,18,19,20-tetranor-2,3-trans-didehydro-pgf2-alpha methyl ester
delprostenato [inn-spanish]
methyl(2e,5z)-7-((1r,2r,3r,5s)-2-((e)-(3r)-4-(m-chloro-phenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-2,5-heptadienoate
methyl (2e,5z)-7-((1r,2r,3r,5s)-2-((e)-(3r)-4-(m-chloro-phenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-2,5-heptadienoate
delprostenatum [inn-latin]
a 2774
62524-99-6
delprostenato
delprostenatum
unii-m99w4q30ol
delprostenate [inn:ban]
m99w4q30ol ,
SCHEMBL571387
delprostenate [inn]
CHEMBL3989453
Q27283717
methyl (2e,5z)-7-[(1r,2r,3r,5s)-2-[(e,3r)-4-(3-chlorophenoxy)-3-hydroxybut-1-enyl]-3,5-dihydroxycyclopentyl]hepta-2,5-dienoate
DTXSID101024278
AKOS040751523
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (28.57)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.91

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.91 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.21 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.91)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (28.57%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (71.43%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
medroxyprogesterone acetate
[no description available]		3.531120-oxo steroid;
3-oxo-Delta(4) steroid;
acetate ester;
corticosteroid;
steroid ester		adjuvant;
androgen;
antineoplastic agent;
antioxidant;
female contraceptive drug;
inhibitor;
progestin;
synthetic oral contraceptive
fertirelin
fertirelin: analog of luteinizing hormone releasing factor; more potent than LHFSHRH; RN given is for releasing factor from pig; RN given refers to parent cpd		1.9610oligopeptide
dinoprost
Dinoprost: A naturally occurring prostaglandin that has oxytocic, luteolytic, and abortifacient activities. Due to its vasocontractile properties, the compound has a variety of other biological actions.. prostaglandin F2alpha : A prostaglandins Falpha that is prosta-5,13-dien-1-oic acid substituted by hydroxy groups at positions 9, 11 and 15. It is a naturally occurring prostaglandin used to induce labor.		5.3472monocarboxylic acid;
prostaglandins Falpha		human metabolite;
mouse metabolite
ConditionIndicatedRelationship StrengthStudiesTrials
Pregnancy
The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.		04.8942